vs
Side-by-side financial comparison of Caledonia Mining Corp Plc (CMCL) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $46.9M, roughly 1.0× Caledonia Mining Corp Plc). Caledonia Mining Corp Plc runs the higher net margin — 7.0% vs -4.8%, a 11.8% gap on every dollar of revenue. On growth, Caledonia Mining Corp Plc posted the faster year-over-year revenue change (13.8% vs -47.3%). Over the past eight quarters, Caledonia Mining Corp Plc's revenue compounded faster (17.1% CAGR vs -20.2%).
Hochschild Mining plc is a leading British-based silver and gold mining business operating in North, Central, and South America. It is headquartered in Lima, Peru, with a corporate office in London, is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The main shareholder is the Peruvian businessman Eduardo Hochschild.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
CMCL vs IRWD — Head-to-Head
Income Statement — Q3 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.9M | $47.7M |
| Net Profit | $3.3M | $-2.3M |
| Gross Margin | 41.2% | — |
| Operating Margin | 18.6% | 14.3% |
| Net Margin | 7.0% | -4.8% |
| Revenue YoY | 13.8% | -47.3% |
| Net Profit YoY | -33.3% | -200.9% |
| EPS (diluted) | $0.13 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $47.7M | ||
| Q3 25 | — | $122.1M | ||
| Q2 25 | — | $85.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | — | $90.5M | ||
| Q3 24 | $46.9M | $91.6M | ||
| Q2 24 | $50.1M | $94.4M | ||
| Q1 24 | $38.5M | $74.9M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | — | $40.1M | ||
| Q2 25 | — | $23.6M | ||
| Q1 25 | — | $-37.4M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $3.3M | $3.6M | ||
| Q2 24 | $10.2M | $-860.0K | ||
| Q1 24 | $2.1M | $-4.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 41.2% | — | ||
| Q2 24 | 45.8% | — | ||
| Q1 24 | 35.9% | — |
| Q4 25 | — | 14.3% | ||
| Q3 25 | — | 61.8% | ||
| Q2 25 | — | 53.2% | ||
| Q1 25 | — | -70.7% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | 18.6% | 28.0% | ||
| Q2 24 | 32.2% | 26.5% | ||
| Q1 24 | 13.8% | 14.7% |
| Q4 25 | — | -4.8% | ||
| Q3 25 | — | 32.8% | ||
| Q2 25 | — | 27.7% | ||
| Q1 25 | — | -90.9% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | 7.0% | 4.0% | ||
| Q2 24 | 20.3% | -0.9% | ||
| Q1 24 | 5.4% | -5.6% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | — | $0.14 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | $0.13 | $0.02 | ||
| Q2 24 | $0.42 | $-0.01 | ||
| Q1 24 | $0.07 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.2M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $231.0M | $-261.8M |
| Total Assets | $339.7M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | $7.2M | $88.2M | ||
| Q2 24 | $15.4M | $105.5M | ||
| Q1 24 | $1.8M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | — | $-261.8M | ||
| Q3 25 | — | $-264.2M | ||
| Q2 25 | — | $-308.2M | ||
| Q1 25 | — | $-334.1M | ||
| Q4 24 | — | $-301.3M | ||
| Q3 24 | $231.0M | $-311.3M | ||
| Q2 24 | $231.1M | $-321.7M | ||
| Q1 24 | $220.3M | $-330.5M |
| Q4 25 | — | $396.9M | ||
| Q3 25 | — | $396.1M | ||
| Q2 25 | — | $342.9M | ||
| Q1 25 | — | $327.2M | ||
| Q4 24 | — | $350.9M | ||
| Q3 24 | $339.7M | $389.5M | ||
| Q2 24 | $338.5M | $395.6M | ||
| Q1 24 | $321.8M | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.6M | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 1.40× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $20.0M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | $4.6M | $9.9M | ||
| Q2 24 | $19.1M | $33.5M | ||
| Q1 24 | — | $45.0M |
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | 1.40× | 2.71× | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
